Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma

Local Institution - 301, Badalona

Local Institution - 108, New York

Local Institution - 107, New York

Local Institution - 302, Pamplona

Local Institution - 106, Tampa

Local Institution - 104, Birmingham

Local Institution - 303, Salamanca

Local Institution - 304, Santander

Local Institution - 101, Milwaukee

Local Institution - 105, Scottsdale

Local Institution - 201, Calgary

Local Institution - 204, Edmonton

Local Institution - 203, Halifax

Local Institution - 202, Toronto

Local Institution - 205, Montreal